...
首页> 外文期刊>Prostaglandins, Leukotrienes, and Essential Fatty Acids >Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.
【24h】

Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.

机译:硝苯地平在环孢素诱导的大鼠肾毒性中的作用:血栓烷和内皮素系统的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cyclosporine (CsA) (45 mg/kg/day for 7 days) administration in female Wistar rats induced significant decrease in creatinine clearance (Ccr) and body weight loss (BWL). Urine volume (V) was not altered and proteinuria (PU) not provoked. These changes were associated with increased urinary endothelin 1 (ET-1) and thromboxane B(2)(TXB(2)) concentrations, and decreased urinary ratios of prostaglandin (6ketoPGF(1 alpha)and PGE(2)) to TXB(2)excretions.Nifedipine (NFD) (0.1 mg/kg/day for 7 days), a calcium channel blocker, administrated in addition to CsA, to another group of animals, significantly augmented Ccr and urine V but did not prevent BWL in comparison to CsA-only treated rats. The urinary ET-1 and TXB(2)concentrations displayed significant and non-significant decrease respectively, while the urinary excretion ratios of 6ketoPGF(1 alpha)/TXB(2)and PGE(2)/TXB(2)were significantly enhanced.These observations indicate that the partial protection of NFD in CsA-induced nephrotoxicity could be attributed to augmented urinary prostanoid ratios of renal vasodilators (6ketoPGF(1 alpha)and PGE(2)) to vasoconstrictor (TXB(2)) excretions, and also to reduced release of rather renal origin ET-1, the most potent mamalian vasoconstrictor peptide known to date. In a previous study, we found that NFD only slightly prevented structural renal damage, induced by CsA. So, the NFD protection refers only to functional toxicity and not to structural damage, mediated at least in part by the preservation of relatively high renal TXB(2)levels. However, other nephrotoxic factors and additional mechanisms could also be implicated in this CsA-induced syndrome. Copyright 2000 Harcourt Publishers Ltd.
机译:在雌性Wistar大鼠中施用环孢素(CsA)(45 mg / kg /天,共7天)导致肌酐清除率(Ccr)和体重减轻(BWL)显着降低。尿量(V)没有改变,蛋白尿(PU)也没有引起。这些变化与尿中内皮素1(ET-1)和血栓烷B(2)(TXB(2))的浓度增加以及前列腺素(6ketoPGF(1 alpha)和PGE(2))与TXB(2)的尿比降低有关。排泄物。除CsA外,对另一组动物使用的钙通道阻滞剂硝苯地平(NFD)(0.1 mg / kg /天,连续7天)显着增加了Ccr和尿液V,但与BWL相比并没有阻止BWL仅CsA处理的大鼠。尿ET-1和TXB(2)的浓度分别显示显着和不显着的降低,而6ketoPGF(1 alpha)/ TXB(2)和PGE(2)/ TXB(2)的尿排泄率显着提高。这些观察结果表明NFD在CsA诱导的肾毒性中的部分保护可能归因于肾血管扩张剂(6ketoPGF(1 alpha)和PGE(2))与血管收缩剂(TXB(2))排泄的尿前列腺素比率增加,以及降低了起源于肾脏的ET-1的释放,ET-1是迄今为止已知的最有效的哺乳动物血管收缩肽。在先前的研究中,我们发现NFD仅能轻微预防CsA引起的结构性肾损害。因此,NFD保护仅是指功能性毒性,而不是结构性损害,至少部分由相对较高的肾脏TXB(2)含量介导。但是,其他肾毒性因子和其他机制也可能与这种CsA诱发的综合征有关。版权所有2000 Harcourt Publishers Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号